August 2017

Royal Philips Acquires Spectranetics in $2B Deal

North America - United States | Europe | Europe - Netherlands | United States - Colorado

Royal Philips acquired Spectranetics, a U.S.-based vascular intervention device maker, in a $2.2 billion deal. Spectranetics' portfolio of devices will aid Philips' strategic expansion into therapy devices. Our firm represented Spectranetics in the acquisition.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.